Auspex Pharmaceuticals Receives $84,000,000 New Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=115547bc-e31a-40ae-a873-a5396ad48f6f
Date
2/5/2014
Company Name
Auspex Pharmaceuticals
Mailing Address
3366 North Torrey Pines Court La Jolla, CA 92037
Company Description
Auspex Pharmaceuticals (NASDAQ: ASPX) is a developer of next-generation medicines with improved safety and performance and a pioneer in the targeted application of deuterium chemistry to clinically validated drugs.
Website
http://www.auspexpharma.com
Transaction Type
IPO
Transaction Amount
$84,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes are on file with company statements at the SEC.
M&A Terms